LETTER TO THE EDITOR
Preoperative c-reactive protein to prealbumin ratio is independently associated with prognosis in patients with resectable colorectal cancer
Qiang Hu MD,
Qiang Hu MD
Department of General Surgery, Tongde Hospital of Zhejiang Province, Hangzhou, China
Search for more papers by this author Kai Feng Zhu MD,
Kai Feng Zhu MD
Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, China
Search for more papers by this author Jing Sun MD,
Corresponding Author
Jing Sun MD
Department of Gastrointestinal Surgery, The Second Affiliated Hospital, Wenzhou Medical University, Wenzhou, China
Correspondence Jing Sun, MD, Department of Gastrointestinal Surgery, The Second Affiliated Hospital, Wenzhou Medical University, 109 Xueyuan RD, Wenzhou 325027, China.
Email: [email protected]
Search for more papers by this author
Qiang Hu MD,
Qiang Hu MD
Department of General Surgery, Tongde Hospital of Zhejiang Province, Hangzhou, China
Search for more papers by this author Kai Feng Zhu MD,
Kai Feng Zhu MD
Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, China
Search for more papers by this author Jing Sun MD,
Corresponding Author
Jing Sun MD
Department of Gastrointestinal Surgery, The Second Affiliated Hospital, Wenzhou Medical University, Wenzhou, China
Correspondence Jing Sun, MD, Department of Gastrointestinal Surgery, The Second Affiliated Hospital, Wenzhou Medical University, 109 Xueyuan RD, Wenzhou 325027, China.
Email: [email protected]
Search for more papers by this author
First published: 02 June 2022
No abstract is available for this article.
CONFLICTS OF INTEREST
The authors declare no conflicts of interest.
REFERENCES
- 1Huang Z, Cai P, Zhao Y, et al. Preoperative C-reactive protein to prealbumin ratio is independently associated with prognosis in patients with resectable colorectal cancer. J Surg Oncol. 2022. doi:10.1002/jso.26823
- 2Agache A, Bîrligea A, Botea S, Cirstea M, Mihalache O, Mustăţea P. Assessment of the risk of colorectal cancer in patients with diabetes mellitus. Chirurgia (Bucur). 2021; 116: 620-626.
- 3Yu G-H, Li S-F, Wei R, Jiang Z. Diabetes and colorectal cancer risk: clinical and therapeutic implications. J Diabetes Res. 2022; 2022:1747326.
- 4Cheong CM, Golder AM, Horgan PG, McMillan DC, Roxburgh CSD. Evaluation of clinical prognostic variables on short-term outcome for colorectal cancer surgery: an overview and minimum dataset. Cancer Treat Res Commun. 2022; 31:100544.
- 5Ozeki T, Shimura T, Ozeki T, et al. The risk analyses of lymph node metastasis and recurrence for submucosal invasive colorectal cancer: novel criteria to skip completion surgery. Cancers (Basel). 2022; 14: 822.
- 6Endo S, Isohata N, Kojima K, et al. Prognostic factors of patients with left-sided obstructive colorectal cancer: post hoc analysis of a retrospective multicenter study by the Japan Colonic Stent Safe Procedure Research Group. World J Surg Oncol. 2022; 20: 24.
- 7Rosenberg R, Friederichs J, Schuster T, et al. Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period. Ann Surg. 2008; 248: 968-978.
- 8Derwinger K, Gustavsson B. A study of lymph node ratio in stage IV colorectal cancer. World J Surg Oncol. 2008; 6: 127.
- 9Wu M, Huang M, He C, et al. Risk of second primary malignancies based on the histological subtypes of colorectal cancer. Front Oncol. 2021; 11:650937.
- 10Miyakawa T, Kawamura H, Honda M, et al. Impact of histological subtype on prognosis in stage IV colorectal cancer: a population-based cohort study. PLoS One. 2022; 17:e0264652.
